KDM2A and breast carcinoma: In this context, breast cancer cell-derived cytokines can stimulate the expression of KDM2A in normal human breast fibroblasts, and KDM2A can induce fibroblast senescence and release more cytokines to promote the proliferation of breast cancer cells, thus forming a vicious cycle [38].